Biotechnology
News Category
VERAXA Biotech Initiates Cell Line Development for Lead BiTAC T-Cell Engager Program
VERAXA Biotech has begun cell line development for its lead BiTAC T-cell engager program, partnering with ATUM to advance the candidate toward IND/CTA...
Quantum BioPharma Ltd. Diversifies Platform to Address Unmet Medical Needs
Quantum BioPharma advances a diversified platform spanning clinical-stage therapeutics, consumer wellness products, and strategic investments to targe...
Ocumetics Advances Toward Commercialization with Positive Clinical Data and Next-Generation Lens
Ocumetics Technology Corp. reports positive six-month clinical results from its first-in-human study, advancing to Group Two surgeries with a redesign...
Oncotelic Therapeutics Launches AI-Powered GMP Manufacturing Platform to Address Biotech Bottleneck
Oncotelic Therapeutics has launched an AI-powered GMP manufacturing services platform aimed at helping emerging biotechs overcome the costly and compl...
Greenland Mines Ltd Advances Skaergaard Project with Expert Workshop
Greenland Mines Ltd's recent development planning workshop for its Skaergaard project marks a key step toward an Initial Assessment, underscoring the ...
VERAXA Biotech Advances Lead BiTAC T-Cell Engager Program with Cell Line Development Partnership
VERAXA Biotech has initiated cell line development for its lead BiTAC T-cell engager program in partnership with ATUM, marking a key step toward IND/C...
NanoViricides Receives Outperform Rating and $6 Price Target from Noble Capital Markets
NanoViricides announced coverage initiation by Noble Capital Markets with an Outperform rating and $6 price target, highlighting its broad-spectrum an...
NanoViricides Receives Outperform Rating and $6 Price Target from Noble Capital Markets
NanoViricides announced independent analyst coverage initiation with an Outperform rating and $6 price target, highlighting its broad-spectrum antivir...
Lantern Pharma Launches AI-Powered ZetaOmics Computational Biology Platform
Lantern Pharma introduced ZetaOmics, an autonomous computational biology platform that automates bioinformatics and multi-omic analysis, expanding its...
Novartis' $1.5B Acquisition of Myricx Bio Highlights Industry Demand for ADC Technologies, Benefiting VERAXA Biotech
Novartis' acquisition of Myricx Bio for up to $1.5 billion underscores the pharmaceutical industry's robust appetite for innovative antibody-drug conj...
Oncotelic Therapeutics Reports Positive Safety Review for Phase 1b Sapu003 Trial, Plans European Expansion
Oncotelic Therapeutics announced its Phase 1b trial of Sapu003 cleared a safety review with no dose-limiting toxicities, advancing to the next dose le...
Oragenics Activates All Australian Phase IIa Trial Sites for Concussion Treatment ONP-002
Oragenics has activated all three Australian sites for its Phase IIa trial of ONP-002 for mild traumatic brain injury, with no serious adverse events ...
VolitionRx Study Demonstrates Prognostic Value of Nu.Q Cancer Assay in Lung Cancer Patients
A new clinical study shows that VolitionRx's Nu.Q Cancer Assay can predict survival outcomes in newly diagnosed lung cancer patients, potentially aidi...
Greenland Mines Adds Two Geologists to Skaergaard Field Campaign, Strengthening Technical Team
Greenland Mines (NASDAQ: GRML) announced the addition of Professor Wolfgang Maier and Associate Professor Kristoffer Szilas to its 2026 Skaergaard fie...
Sustained Release Polymers Market Set to Reach USD 7.8 Billion by 2036, Driven by Chronic Disease Management and Drug Delivery Innovation
The sustained release polymers market is projected to grow from USD 3.8 billion in 2026 to USD 7.8 billion by 2036 at a CAGR of 7.4%, driven by rising...
VERAXA Biotech Highlights BiTAC Pipeline Progress and Partnering Strategy in First Half 2026 Update
VERAXA Biotech provided a corporate update detailing advancement of its proprietary BiTAC platform, four T-cell engager programs, and a strategy to mo...
The New Rules of Biotech Now Available in Hardcover and Audiobook
The book by David Craig provides a modern guide for building biotech companies amid changed market conditions, now accessible in multiple formats.
VERAXA Biotech Positioned Amidst Surge in ADC Acquisitions as Novartis Snaps Up Myricx Bio for $1.5 Billion
Novartis's $1.5 billion acquisition of Myricx Bio underscores the booming demand for next-generation antibody-drug conjugate technologies, validating ...
VERAXA Biotech Highlights BiTAC Pipeline Progress and Advances Partnering Strategy
VERAXA Biotech reported progress in its BiTAC platform and partnering strategy, with a pipeline of four BiTAC-based T-cell engager programs and plans ...
VERAXA Biotech Advances BiTAC Pipeline and Partnering Strategy, Targeting IND by Early 2028
VERAXA Biotech AG (NASDAQ: VRXA) reported progress in its BiTAC platform, with four T-cell engager programs in development and plans to advance lead c...
VERAXA Biotech Initiates Cell Line Development for Lead BiTAC Cancer Therapy Program
VERAXA Biotech has started cell line development for its lead BiTAC T-cell engager program, leveraging ATUM's Leap-In Transposase technology to advanc...
Gut Microbiome Found to Influence Immunotherapy Success in Liver Cancer
A comprehensive review reveals that the gut microbiome plays a crucial role in determining patient response to immunotherapy for liver cancer, opening...
LIXTE Biotechnology Completes NOMAD Merger, Rebrands as NOMAD Power Solutions to Focus on Battery Storage
LIXTE Biotechnology Holdings Inc. has completed its merger with NOMAD Transportable Power Systems, changing its name to NOMAD Power Solutions Inc. and...
VERAXA Biotech Initiates Cell Line Development for Lead BiTAC Cancer Therapy Program, Aiming to Improve Tumor Selectivity
VERAXA Biotech has started cell line development for its lead BiTAC T-cell engager program through a collaboration with ATUM, following encouraging pr...
VERAXA Biotech (VRXA) Positioned to Capitalize on Strong Antibody Therapeutics Deal Activity
The article highlights how VERAXA Biotech, with its platform technology in ADCs and T-cell engagers, stands to benefit from the robust strategic licen...
Quantum BioPharma Executive Details Lucid-MS Strategy and unbuzzd Update in Podcast Interview
Quantum BioPharma executive co-chairman Anthony Durkacz discusses the company's MS drug candidate Lucid-MS and its alcohol metabolism accelerator unbu...
VERAXA Biotech AG: Strategic Partnerships in Antibody Therapeutics Highlight Sector Value
The article discusses how deal activity in antibody-drug conjugates and T-cell engagers creates value for companies like VERAXA Biotech AG, emphasizin...
MindBio Therapeutics Delivers First Edge AI Intoxication Detection Kiosk Prototypes for Workplace Safety
MindBio Therapeutics has completed and delivered its first prototype Edge AI Intoxication and Fatigue Detection Kiosks, which use voice analysis to de...
Quantum BioPharma Showcases MS Drug Candidate and Growth Strategy on Executive Podcast
Quantum BioPharma's executive co-chair Anthony Durkacz discussed the company's lead MS drug Lucid-MS and alcohol metabolism accelerator unbuzzd on the...
Annovis Bio Promotes Cheng Fang to Chief Scientific Officer, Advancing Alzheimer’s and Parkinson’s Programs
Annovis Bio promoted Cheng Fang to Chief Scientific Officer as the company nears top-line data from its pivotal Phase 3 Alzheimer’s study, underscorin...
Onco-Innovations Announces CAD$5 Million Private Placement to Advance Cancer Programs
Onco-Innovations Limited has signed a term sheet for a CAD$5 million private placement to fund its ONC010 program and SynoGraph platform, with closing...
Onco-Innovations Advances ONC010 Manufacturing Development With Nanosoft Polymers
Onco-Innovations partners with Nanosoft Polymers to develop scalable manufacturing for its lead nanoparticle drug candidate ONC010, advancing toward c...
GeoVax Highlights U.S. Government Investment in Orthopox Preparedness as Validation of Vaccine Readiness
GeoVax comments on recent U.S. procurement of smallpox vaccine, emphasizing sustained federal commitment to orthopox preparedness and alignment with i...
Active Hybrid Humidification Incubator Market to Reach USD 229.2 Million by 2036, Driven by Advanced Cell Culture Demands
The active hybrid humidification incubator market is projected to grow from USD 90.0 million in 2026 to USD 229.2 million by 2036, driven by increasin...
Helix BioPharma Strengthens Executive Leadership Ahead of U.S. Listing and Next Clinical Phase
Helix BioPharma appointed Helen Middleton as General Counsel and David Browning as VP of Clinical Operations to support its planned U.S. exchange list...
HeartBeam Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study
HeartBeam has completed patient enrollment early in its ALIGN-ACS pilot study for heart attack detection using its 3D ECG technology, with results exp...
Cardio Diagnostics Holdings Leverages Epigenetics to Reveal Hidden Heart Disease Risks
Cardio Diagnostics Holdings (CDIO) uses epigenetics to assess heart disease risk beyond genetics, offering insights into how lifestyle and environment...
TechForce Robotics Expands RaaS Platform into Laboratory Automation with Oncotelic Deployment
TechForce Robotics completed its first pharmaceutical deployment of the LIM-E autonomous lab robot at Oncotelic Therapeutics and announced a strategic...
Silo Pharma Advances SPC-15 Intranasal PTSD Program With Device Robustness Study
Silo Pharma announced a robustness study for its intranasal PTSD treatment SPC-15, supporting regulatory guidance and Phase 1 trial design.
Onco-Innovations Advances Manufacturing of Novel PNKP Inhibitor for Hard-to-Treat Cancers
Onco-Innovations Ltd. has achieved a key manufacturing milestone for its lead drug candidate ONC010 and signed a Letter of Intent with Nanosoft Polyme...
Amerigo Scientific Launches High-Quality iPSC-Derived Cells to Advance Biomedical Research and Cell Therapy
Amerigo Scientific released high-purity iPSC-derived cells and engineered reporter lines, offering tools for disease modeling, drug screening, and cel...
Creative Enzymes Launches AI-Integrated Biocatalysis Platform to Accelerate Enzyme Development
Creative Enzymes' new AI-integrated platform bridges the gap between computational enzyme design and industrial-scale biocatalysis, reducing developme...
Creative Biolabs Enhances Drug Discovery with Custom Oligosaccharide Synthesis and Glycan Characterization
Creative Biolabs integrates advanced synthesis and analytical platforms to provide structurally validated oligosaccharides, addressing key challenges ...
Quantum BioPharma Reaches Midpoint in Multiple Sclerosis Imaging Study, Early Results Show Promise
Quantum BioPharma announced that patient enrollment in its collaborative imaging study with Massachusetts General Hospital has reached the halfway poi...
SUIC and VisionRenu Sign Strategic MOU to Accelerate AI Biotechnology, Precision Medicine, and U.S. Capital Market Expansion
SUIC Worldwide Holdings and VisionRenu Biomedical have signed a strategic MOU to collaborate on AI-powered biotechnology, precision medicine, and inte...
Cardio Diagnostics Leverages Epigenetics to Uncover Hidden Heart Disease Risks
Cardio Diagnostics Holdings uses epigenetics to assess cardiovascular risk beyond genetics, offering insights into how lifestyle and environment affec...
Oncotelic Therapeutics Publishes Peer-Reviewed Validation of Deciparticle Platform, Advancing Intravenous Everolimus Formulation
The peer-reviewed validation of Oncotelic's Deciparticle platform supports its potential to enable intravenous delivery of poorly water-soluble drugs,...
Tonix Pharmaceuticals Enrolls First Patient in Phase 2 Trial of TNX-102 SL for Major Depressive Disorder
Tonix Pharmaceuticals has enrolled the first patient in a Phase 2 trial evaluating TNX-102 SL as a monotherapy for major depressive disorder, potentia...